SFA Therapeutics to Present Human Psoriasis Data for Microbiomebased Drug SFA002 at the Global Biotech Entrepreneur Forum and the BIO International Convention

Also Presenting Preclinical Data on Two Additional Pipeline Products SFA Therapeutics Inc. will be presenting human Psoriasis data on its humanmicrobiomebased drug SFA002 as well as preclinical data for two additional pipeline pr...